Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Market watchers are predicting strong growth driven by the continued success of Lilly's blockbuster treatments, particularly its insulin portfolio. However, there are also concerns about potentia… Read More